药物发现,开发和制造 499条(本栏目收费,不能显示细节,电话15274084725)
An Introduction to Toxicogenomics 4477
Role of Bioactivation Reactions in
Chemically Induced Nephrotoxicity 4501
Drug Metabolism in Regulatory
Guidances, Clinical Trials, and
Product Labeling 4523
Drug Development
Process and Global
Pharmaceutical
Marketplace 4739
Regulation of Human
Pharmaceutical Safety 4757
Prior Art and Its
Use in Safety
Assessment Process 4827
Screens in Safety and
Hazard Assessment 4841
Formulations, Routes, and
Dosage Design 4859
Single - Dose (Acute) and
Pilot ( DRF ) Toxicity
Testing in Drug Safety
Evaluation 4923
Repeat - Dose Toxicity
Studies 5042
Immunotoxicology in
Drug Development 5064
Nonrodent Animal
Studies 5138
Developmental
and Reproductive
Toxicity Testing 5179
Carcinogenicity Studies 5219
Histopathology in
Nonclinical
Pharmaceutical Safety
Assessment 5258
Irritation and Local
Tissue Tolerance in
Pharmaceutical Safety
Assessment 5269
Pharmacokinetics and
Toxicokinetics in Drug
Safety Evaluation 5306
Special Concerns for
Preclinical Evaluation of
Biotechnology Products 5382
Safety Assessment of
Inhalant and Dermal
Route Drugs 5426
Special - Case Products:
Imaging Agents and
Oncology Drugs 5463
Occupational Toxicology
in Pharmaceutical
Industry 5475
Strategy and Phasing for
Nonclinical Drug Safety
Evaluation in Discovery
and Development of
Pharmaceuticals 5497
Application of In Vitro
Techniques in Drug
Safety Assessment 5526
Evaluation of Human
Tolerance and Safety in
Clinical Trials: FIM Trials
and Beyond 5599
Postmarketing Safety
Evaluation: Monitoring,
Assessing, and
Reporting of Adverse
Drug Responses 5673
Statistics in
Pharmaceutical
Safety Assessment 5710
Combination Products:
Drugs and Devices 5821
Qualifi cation of
Impurities, Degradants,
Residual Solvents,
and Leachables
in Pharmaceuticals 5838